Tata Chemicals signs MoU with BSDT’s Integrated Cancer Treatment and Research Centre, Pune

Tata Chemicals has signed a Memorandum of Understanding (MoU) with Bharatiya Sanskriti Darshan Trust (BSDT) – BSDT’s Integrated Cancer Treatment and Research Centre (ICTRC) in Pune. This collaboration aims to explore the beneficial effects of TCL’s prebiotic, soluble dietary fibres, and their derivatives on gut health and overall wellness. 

The MoU was signed in the presence of Tata Chemicals’ R&D team, led by Dr Richard Lobo, and the BSDT team, led by Dr Sushrut S. Sardeshmukh, Trustee, BSDT, and Dr Vineeta V. Deshmukh, Deputy Director, ICTRC. This partnership will focus on integrating scientific research with Ayurvedic principles to develop advanced solutions for health and wellness.

Speaking on the occasion of signing the MoU, Dr Richard Lobo – Head – Innovation, R&D, Business Excellence and Chief Ethics Counsellor at Tata Chemicals said “We are committed to working together in understanding and improving the functionality of our science-differentiated products in Ayurvedic formulations, for improving the quality of life & alleviating pain through Ayurvedic disciplines.”

Dr Sushrut S. Sardeshmukh, Trustee at Bharatiya Sanskriti Darshan Trust added “This collaboration is a significant step towards advancing research in Ayurveda integrated in wellness products with science-backed innovations. By combining our expertise in holistic healing with Tata Chemicals’ commitment to Innovative products, we aim to further explore solutions that support holistic well-being.”